Pegasys treatment copegus

Common Questions and Answers about Pegasys treatment copegus

pegasys

476246 tn?1418870914 26June2008 Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.
Avatar f tn * Safety and tolerability for the 4-week treatment period were similar for R7128 with Pegasys plus Copegus compared to placebo with Pegasys plus Copegus. There were no serious adverse events reported during the 4-week treatment period, and most of the adverse events reported were of mild to moderate intensity.
Avatar f tn i am a non responder,after 2 previous tratments with other interferons,now after having a liver biopsy my dr wants me to go on pegasys with copegus, he wants to prescribe the 180mcg/0.5ml shot along which is prefilled but he wants me to take some of the other prefilled shot which would make it more than the normal 180 mcg. i did not ask him exactly how much it will total cause i have doubts about this,i have never heard of this. and may just stick with the 180 once a week.
Avatar f tn Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1. Pharmasset expects to initiate a 12-week Phase 2b study of PSI-7977 in the fourth quarter of 2010.
Avatar f tn has anyone treated with Pegasys and Copegus instead of Sovaldi and Ribavarin, and if so are the results the same?
Avatar m tn 4 Dose Modifications If severe adverse reactions or laboratory abnormalities develop during combination PEGASYS/COPEGUS therapy, the dose should be modified until the adverse reactions abate. If intolerance persists after dose adjustment, PEGASYS/COPEGUS therapy should be discontinued. Table 3, Table 4, Table 5, and Table 6 provide guidelines for dose modifications and discontinuation of PEGASYS/COPEGUS based on laboratory abnormalities, patient’s depression status, and cardiac status.
Avatar f tn I am going through a county program for the health care part and then I went through Pegassist for the injections and meds. The health care program I am in is a 2 year program and it is for the county I live in in CO.
Avatar m tn I am on pegasys but that is because I am in a trial for a polymerase inhibitor called R7128 which is done in conjunction with Roche, who makes pegasys and copegus. The trial gives all three drugs. For what it is worth I was told by others that pegasys sides were more tolerable than PegIntron but you know what, if they are it still *****! LOL I hope this helps and welcome to the forum.
Avatar m tn Do you know any tx for anemia caused by ribavirin other than 1) procrit or 2) greatly reducing ribavirin intake for patients on telaprevir, with pegasys, and ribavirin that will increase hemoglobin levels?
Avatar n tn I was told the cost for a 48 wk treatment of peginterferon/ribaviron (pegasys and copegus) was around $30,000. I am a self employed single wage earner with no medical insurance. I spoke with my Dr. and because of my income they helped me apply to Pegassist through Genentech. I get all my meds at no charge but I am responsible for the cost of all lab work through the 11 months and dr. office calls.
2030686 tn?1351688548 COPEGUS should be given in combination with PEGASYS; it is important to note that COPEGUS should never be given as monotherapy. See PEGASYS Package Insert for all instructions regarding PEGASYS dosing and administration. 2.1 Chronic Hepatitis C Monoinfection Adult Patients The recommended dose of COPEGUS tablets is provided in Table 1. The recommended duration of treatment for patients previously untreated with ribavirin and interferon is 24 to 48 weeks.
Avatar m tn 53am BST ZURICH, June 26 (Reuters) - Roche Holding AG said on Thursday it had received European Union approval for a shortened treatment course for Pegasys in combination with Copegus for certain hepatitis C patients. The 16-week course will be available for patients with genotype 2 or 3 strains of chronic hepatitis C who have low virus levels before starting treatment and show rapid virological response, the Basel-based drug maker said.
Avatar n tn It is a medicine that works by slowing down the growth of the virus. COPEGUS should be taken with PEGASYS to fight the virus. Schering-Plough's PEGINTRON (peginterferon alfa-2b) Powder for Injection and INTRON A (interferon alfa-2b, recombinant) for Injection, or INTRON A therapy should be taken with REBETOL (ribavirin, USP) Capsules.
Avatar f tn The trial is evaluating the dose and duration of treatment with RG7128 in combination with Pegasys [pegylated interferon alfa-2a] plus Copegus (ribavirin). The primary efficacy endpoint of the trial is the proportion of patients achieving an SVR, defined as serum HCV RNA below the limit of detection as measured by the Roche TaqMan assay 24 weeks after completion of treatment.
Avatar f tn This is listed on the safety infomation for Pegasys on Copegus but please note it says "rarely". Liver problems (rarely, liver function worsens) including an increased chance of liver failure in patients with cirrhosis. Patients with both the hepatitis C virus and HIV have an increased chance of liver failure during PEGASYS treatment. Change in a blood test that measures liver inflammation occurs more often in patients with hepatitis B.
Avatar f tn Has anybody out there been treated with COPEGUS and PEGASYS? I saw a gastroentoligist today and he has ordered all sorts of blood work, but says if I start treatment this is what he would give me. I asked about the new VERTEX drug coming out next year and he said it probably wouldent be out that soon.
Avatar m tn The ONLY proven treatment for Hepatitis C is currently the chemotherapy combination of Interferon and Ribavirin. Brand names are Pegasys, Copegus and Infergen - there are others, I believe - but you'll have to find them.
Avatar f tn Here is a webpage with many links to the IDEAL study; this was sponsored by Schering Plough Pharmaceuticals to evaluate the differences between the two drugs. Not an easy task, as the results show. The official party line indicates there is very little difference between the two drugs in treatment outcomes, but there has been discussion about the study design that might be less than ideal :o). http://tinyurl.